Post-authorisation active surveillance of the Safety of COVID-19 Vaccine AstraZeneca (AZD-1222) in the UK: A consortium study

First published 05/11/2021

Last updated 24/05/2024

EU PAS number:

EUPAS44035

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

COVID vaccine AZD-1222 protocol v1.7_31_10_22_Abstract.pdf

English (97.95 KB - PDF)View document

Study results

Study report

Study report

COVID vaccine AZD-1222 Final report Abstract_v0.2.pdf

English (55.5 KB - PDF)View document

Other information